Brette L. Trost
Lawyers
Associate in our IP, Tech & Commercial Transactions practice. Previously completed a rotation in Mergers & Acquisitions.
Experience highlights
Recent Representations
- Biodesix $55 million follow-on offering
- MediaAlpha $59.6 million secondary offering
- Prime Medicine $161 million stock and pre-funded warrants offering
- Estée Lauder $650 million senior notes offering
- Truist sale of Sterling Capital Management to Guardian Capital
- TKO Group Holdings $666 million secondary offering
- GSK exclusive license agreement for HS-20089 with Hansoh Pharma
- Ferrara Candy acquisition of Jelly Belly Candy
- HilleVax $115 million follow-on offering
- Natera $250 million follow-on offering
- Upgrade $100 million acquisition of Uplift
- Centogene strategic collaboration with Lifera
- Estée Lauder $2 billion senior notes offering
- TPG acquisition of majority stake in Thomson Reuters’ Elite business
- Alteryx $450 million senior notes offering
- CureVac $250 million follow-on offering
Education
J.D., New York University School of Law
- magna cum laude
- Order of the Coif
- Managing Editor, New York University Journal of Intellectual Property & Entertainment Law
B.A., English, University of Pennsylvania
- summa cum laude
Professional history
- Davis Polk since 2019
Qualifications and admissions
- State of New York